SELLAS Life Sciences Group, Inc.
SLS
SLS
Nasdaq
Health Technology
Pharmaceuticals: Major
14.35
USD-1.115
-7.21%
Open: 08-24 19:39 (UTC+0)
SLS Key Statistics
High
15.48
Open
15.48
Volume
7.05M
Low
13.91
Prev. Close
15.46
Trading Value
101.07M
52-Week High
15.88
Relative Volume
1.129
Amplitude (%)
10.16%
52-Week Low
1.39
Turnover Rate
3.49%
Market Cap
2.89B
P/E Ratio (TTM)
--
P/E Ratio (Annual)
--
P/B Ratio
22.68
P/S Ratio
--
Earnings Per Share (EPS)
-0.212
Dividend (TTM)
0
Dividend Yield
0.00%
Shares Outstanding
201.94M
Currency Unit
USD
SLS Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
SLS Money Flow Distribution
SLS Daily Short Sale Volume
SLS Short Interest History
SLS Stock Snapshot
As of 2026-08-24, the SELLAS Life Sciences Group, Inc. (SLS) stock price today is 14.345. Based on this price, the company has a market capitalization of $2.89B, with a P/E ratio of --.
On 2026-08-24, SLS traded between 13.91 and 15.48. Today’s stock price is 3.13% above the daily low and 7.33% below the daily high, placing SLS in the lower range of its most recent trading range.
Trading volume currently stands at 7.05M, compared with an average daily volume of 6.24M. This suggests that trading activity is roughly in line with its usual level than usual.
Over the past year, SELLAS Life Sciences Group, Inc. shares have traded between 1.39 and 15.88. At today’s price, SLS is 932.01% above its 52-week low and 9.67% below its 52-week high.
SLS Related News
About SLS
Company Name
SELLAS Life Sciences Group, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
Nasdaq
Number of Employees
13
Lot Size
100
Official Website
Currency Unit
USD
SELLAS Life Sciences Group, Inc. (SLS) is a late-stage biopharmaceutical company developing cancer immunotherapies. Its programs include galinpepimut-S, a WT1-targeted vaccine, and SLS009, a selective CDK9 inhibitor.
Related Stocks
SLS FAQ
© 2026 CoinGlass, all rights reserved
